Cargando…
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
BACKGROUND: Glioblastoma is currently an incurable cancer. Genome-wide association studies have demonstrated that 41 genetic variants are associated with glioblastoma and may provide an option for drug development. METHODS: We investigated FDA-approved antipsychotics for their potential treatment of...
Autores principales: | Lin, Wei-Zhi, Liu, Yen-Chun, Lee, Meng-Chang, Tang, Chi-Tun, Wu, Gwo-Jang, Chang, Yu-Tien, Chu, Chi-Ming, Shiau, Chia-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815269/ https://www.ncbi.nlm.nih.gov/pubmed/35120529 http://dx.doi.org/10.1186/s12967-021-03209-2 |
Ejemplares similares
-
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022) -
Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy
por: Wu, Chia-Hsien, et al.
Publicado: (2016) -
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017) -
Repurposing Antipsychotics for Cancer Treatment
por: Vlachos, Nikolaos, et al.
Publicado: (2021) -
Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)